TXG News and Press, 10x Genomics Inc.

10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...

A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...

2024-07-10 14:34:27 ET Summary 10x Genomics' share price is down nearly 15% today and >70% year-to-date. The company offers innovative products for biological analysis but faces heavy losses and declining revenues of key products. The acquisition of Fluent Biosciences by Il...

2024-07-10 11:46:27 ET More on 10x Genomics 10x Genomics: Sticking To The Plan To Avoid The Falling The Knife 10x Genomics, Inc. (TXG) Q1 2024 Earnings Call Transcript 10x Genomics stock slides amid German patent court ruling 10x Genomics Q1 2024 Earnings Pre...

A look at the top 10 most actives in the United States Longeveron Inc. (LGVN) rose 69.0% to $4.8499 on volume of 46,980,986 shares Virpax Pharmaceuticals Inc. (VRPX) rose 161.5% to $3.0333 on volume of 46,199,502 shares Maxeon Solar Technologies Ltd. (MAXN) fell 0.6% to $0.2464 on volume ...

2024-07-05 03:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-28 07:15:04 ET Barclays analyst issues OVERWEIGHT recommendation for TXG on June 28, 2024 05:28AM ET. The previous analyst recommendation was Overweight. TXG was trading at $19.85 at issue of the analyst recommendation. The overall analyst consensus : HOLD. C...

2024-06-27 10:17:45 ET Information Technology has been the best performing name among all 11 S&P 500 ( SP500 ) sectors in the first half of 2024, but Cathie Wood’s actively managed ARK Innovation ETF ( NYSEARCA: ARKK ) - which aims to provide investors exposure to dis...

New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies PR Newswire Researchers used Chromium Single Cell products and Xenium In Situ to profile how gene expression is spatially regulated during secondary palate formation PLEASAN...

2024-06-27 06:15:04 ET Wolfe Research analyst issues PEER PERFORM recommendation for TXG on June 27, 2024 04:49AM ET. TXG was trading at $19.5 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 3 - Buy, 5 -...